Suzanne Groah, MD
Physical Medicine & Rehabilitation · Washington, DCNPI 1750391967
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,448 of the $2,448 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AbbVie. Among physical medicine & rehabilitation clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2 payments — averaging $1224.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
Across 23 payments — averaging $4062.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tanabe Pharma America, Inc.$72K
- GW Research Limited$13K
- AbbVie$6K
- Jazz Pharmaceuticals Inc.$3K
What the payments were for
- Consulting fees$2,448100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $2,448 |
How this compares
$2,448 in reported general payments places this provider in the 95th percentile of 41 physical medicine & rehabilitation providers in District of Columbia.
See all physical medicine & rehabilitation providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 45 | $1,192 |
| Pregabalin | 16 | $569 |
| Gabapentin | 21 | $343 |
| Methadone Hcl | 11 | $58 |
| Nortriptyline Hcl | 11 | $44 |
| Diazepam | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Washington
- Richard ZorowitzWashington$57K
- Ryan AschenbrenerWashington$8K
- Eric WisotzkyWashington$2K
- Nikolai KhromouchkineWashington$2K
- Erika GosaiWashington$1K
- Nathan YokelWashington$1K
- Howard GilmerWashington$700
- Jasmine MalhotraWashington$670
- Michael WrotenWashington$586
- Megha MandalaywalaWashington$464
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.